Thelansis

Coronary Microvascular Disease (CMD) Market Outlook Thelansis’s “Coronary Microvascular Disease (CMD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Coronary Microvascular Disease (CMD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the grea...

Coronary Microvascular Disease (CMD) Market Outlook Thelansis’s “Coronary Microvascular Disease (CMD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Coronary Microvascular Disease (CMD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Coronary Microvascular Disease (CMD) Overview Coronary microvascular disease (CMD) is a group of disorders that affect the structure and function of coronary microcirculation. CMD is prevalent in patients with various cardiovascular risk factors and is associated with an increased risk of adverse events. Several potential causes for microvascular dysfunction have been identified, including cardiov...

 Coronary microvascular disease (CMD) is a group of disorders that affect the structure and function of coronary microcirculation. CMD is prevalent in patients with various cardiovascular risk factors and is associated with an increased risk of adverse events. Several potential causes for microvascular dysfunction have been identified, including cardiovascular risk factors, impaired vasodilatation capacity, and endothelium-dependent and endothelium-independent mechanisms. Patients with CMD may have chest pain that can persist even after cessation of activity. CMD is divided into four major categories: (1) CMD in the absence of coronary artery and myocardial disease, (2) CMD in the presence of myocardial diseases such as hypertrophic cardiomyopathy, dilated cardiomyopathy, hypertension, aortic stenosis, and infiltrative heart disease, (3) CMD in the presence of obstructive coronary artery diseases such as stable coronary artery disease and acute coronary syndromes, and (4) iatrogeni...